Developing materials to improve stem cell-derived insulin-producing cells for diabetes treatment
BIOMATERIALS FOR STEM CELL-DERIVED BETA CELL TRANSPLANTATION
This study is looking for new materials that can help grow and improve insulin-producing cells from stem cells, aiming to provide a better treatment option for people with Type 1 diabetes without the need for ongoing medication to prevent rejection.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Georgia Institute of Technology NIH-funded |
| Lab location | 1 site (Atlanta, United States) |
| Project ID | NIH-10912650 on NIH RePORTER |
What this research studies
This research focuses on finding new biomaterials that can enhance the maturation and function of insulin-producing beta cells derived from human pluripotent stem cells. The goal is to create a reliable source of these cells for patients with Type 1 diabetes, which affects millions in the U.S. The project aims to eliminate the need for chronic immunosuppression, which is currently required for cell transplantation. By engineering these biomaterials, the research seeks to improve the long-term success of beta cell transplants.
Who could benefit from this research
Good fit: Ideal candidates for this research are adults with Type 1 diabetes who are seeking alternatives to traditional insulin therapy.
Not a fit: Patients with Type 2 diabetes or those who do not have diabetes may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could provide a more effective and sustainable treatment option for individuals with Type 1 diabetes, potentially reducing their reliance on insulin therapy.
How similar studies have performed: Previous research has shown promise in using stem cell-derived beta cells for diabetes treatment, but this approach aims to address significant challenges that have yet to be fully resolved.
Where this research is happening
Atlanta, United States
- Georgia Institute of Technology — Atlanta, United States (Active)
Researchers
- Principal investigator: Garcia, Andres J — Georgia Institute of Technology
- Study coordinator: Garcia, Andres J
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.